Literature DB >> 9931196

Effects of acetaminophen and ibuprofen on renal function in the stressed kidney.

W B Farquhar1, A L Morgan, E J Zambraski, W L Kenney.   

Abstract

Exercise, salt restriction, and/or dehydration causes transient reductions in renal function that may be buffered by vasodilatory prostaglandins (PGs). Over-the-counter (OTC) analgesics have the potential to alter renal hemodynamics by inhibiting renal PGs. Therefore, we tested the renal effects of the maximal recommended dose of acetaminophen (Acet, 4 g/day) and ibuprofen (Ibu, 1.2 g/day) vs. a placebo (Pl) in humans subjected to progressive renal stresses. After baseline measurements, 12 fit young (25 +/- 1 yr) men and women underwent 3 days of a low (10 meq/day)-sodium diet while taking one of the drugs or Pl (crossover design). Day 4 involved dehydration (-1.6% body wt) followed by 45 min of treadmill exercise (65% maximal O2 uptake) in the heat (36 degreesC). These combined stressors caused dramatic decreases in effective renal plasma flow, glomerular filtration rate (GFR), and sodium excretion. Baseline GFR (range: 118-123 ml/min) decreased to 78 +/- 4, 73 +/- 5, and 82 +/- 5 ml/min postexercise in the Acet, Ibu, and Pl trials, respectively, with a significantly greater decrease in GFR in the Ibu trial (P < 0. 05 vs. Pl). OTC Ibu has small but statistically significant effects on GFR during exercise in a sodium- and volume-depleted state; OTC Acet was associated with no such effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931196     DOI: 10.1152/jappl.1999.86.2.598

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  19 in total

1.  National Athletic Trainers' Association Position Statement: Fluid Replacement for the Physically Active.

Authors:  Brendon P McDermott; Scott A Anderson; Lawrence E Armstrong; Douglas J Casa; Samuel N Cheuvront; Larry Cooper; W Larry Kenney; Francis G O'Connor; William O Roberts
Journal:  J Athl Train       Date:  2017-09       Impact factor: 2.860

2.  A toxicological study on photo-degradation products of environmental ibuprofen: Ecological and human health implications.

Authors:  Nishanthi Ellepola; Talysa Ogas; Danielle N Turner; Rubi Gurung; Sabino Maldonado-Torres; Rodolfo Tello-Aburto; Praveen L Patidar; Snezna Rogelj; Menake E Piyasena; Gayan Rubasinghege
Journal:  Ecotoxicol Environ Saf       Date:  2019-11-12       Impact factor: 6.291

Review 3.  A guideline for the inpatient care of children with pyelonephritis.

Authors:  Aftab S Chishti; Erich C Maul; Rubén J Nazario; Jeffrey S Bennett; Stefan G Kiessling
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

Review 4.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

Review 5.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

Review 6.  Use of nonsteroidal anti-inflammatory drugs following exercise-induced muscle injury.

Authors:  Angela Baldwin Lanier
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

7.  Intramuscular ketorolac injections in the athlete.

Authors:  Gregory A Sawyer; Brett C Anderson; Neha P Raukar; Paul D Fadale
Journal:  Sports Health       Date:  2012-07       Impact factor: 3.843

8.  Soft tissue injections in the athlete.

Authors:  Jeffrey J Nepple; Matthew J Matava
Journal:  Sports Health       Date:  2009-09       Impact factor: 3.843

Review 9.  Foot and Ankle Injections in Athletes.

Authors:  Jonathan K Ochoa; Christopher E Gross; Robert B Anderson; Andrew R Hsu
Journal:  Sports Health       Date:  2021-03-24       Impact factor: 4.355

10.  Injectable Ketorolac and Corticosteroid Use in Athletes: A Systematic Review.

Authors:  Timothy R Jelsema; Anthony C Tam; James L Moeller
Journal:  Sports Health       Date:  2020-09-02       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.